The total return over the past 12 months is -38.07% vs. +16.94% for the S&P 500. So far it's up -74.22% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (38.07%) | (9.36%) | (34.76%) | (29.99%) | N/A | N/A |
| Total Return CAGR | (38.07%) | (9.36%) | (34.76%) | (29.99%) | N/A | N/A |
| Revenue CAGR | (62.70%) | +205.52% | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Lipocine Inc. (LPCN)
| Year | Start price | End price | LPCN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $8.03 | $2.07 | (74.22%) | +14.51% | (88.73%) |
| 2025 | $4.88 | $8.03 | +64.55% | +17.72% | +46.83% |
| 2024 | $2.79 | $4.88 | +74.91% | +24.89% | +50.02% |
| 2023 | $6.77 | $2.79 | (58.79%) | +26.19% | (84.98%) |
| 2022 | $16.85 | $6.77 | (59.82%) | (18.17%) | (41.65%) |
| 2021 | $23.12 | $16.85 | (27.12%) | +28.74% | (55.86%) |
| 2020 | $6.55 | $23.12 | +252.98% | +18.37% | +234.61% |
| 2019 | $22.10 | $6.55 | (70.36%) | +31.22% | (101.58%) |
| 2018 | $58.48 | $22.10 | (62.21%) | (4.56%) | (57.65%) |
| 2017 | $62.56 | $58.48 | (6.52%) | +21.70% | (28.22%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
